A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect

Clinical Pharmacology and Therapeutics

Volumn 61, Issue 1, 1997, Pages 45-58

  Billard, Valérie ^a,b   Gambus, Pedro L ^a,c   Chamoun, Nassib ^a,d   Stanski, Donald R ^a,e   Shafer, Steven L ^a,e  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d Aspect Medical Systems Inc   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; MIDAZOLAM; PROPOFOL;

ADULT; ARTICLE; DRUG EFFECT; ELECTROENCEPHALOGRAM; HUMAN; MALE; NORMAL HUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; SPECTROSCOPY; VOLUNTEER;

ADULT; AGED; ALFENTANIL; ANESTHETICS, INTRAVENOUS; ELECTROENCEPHALOGRAPHY; HUMANS; MALE; MIDAZOLAM; MIDDLE AGED; PROPOFOL; RETROSPECTIVE STUDIES;

EID: 0031018117     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(97)90181-8     Document Type: Article

References (37)

1. Stanski DR. Pharmacodynamic modeling of anesthetic EEG drug effects. Annu Rev Pharmacol Toxicol 1992;32:423-47.
2. Russell GB, Rodichok LD. Computerized electroen-cephalogram analysis. In: Russell GB, Rodichok LD, editors. Primer of intraoperative neurophysiologic monitoring. Boston: Butterworth-Heinemann, 1995: 81-96.
3. Schwilden H. Use of the median EEG frequency and pharmacokinetics in determining depth of anaesthesia. In: Jones JG, editor. Depth of anaesthesia. London: Baillière's, 1989:603-21.
4. Rampil IJ, Matteo RS. Changes in EEG spectral edge frequency correlate with the hemodynamic response to laryngoscopy and intubation. Anesthesiology 1987; 67:139-42.
5. Levy WJ. Power spectrum correlates of changes in consciousness during anesthetic induction with enflurane. Anesthesiology 1986;64:688-93.
6. Forrest FC, Tooley MA, Saunders PR, Prys-Roberts C. Propofol infusion and the suppression of consciousness: the EEG and dose requirements. Br J Anaesth 1994;72:35-41.
7. Scott JC, Ponganis KV, Stanski DR. EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil. Anesthesiology 1985;62:234-41.
8. Scott JC, Cooke JE, Stanski DR. Electroencephalographic quantitation of opioids effects: comparative pharmacodynamics of fentanyl and sufentanil. Anesthesiology 1991;74:34-42.
9. Sneyd JR, Samra SK, Davidson B, Kishimoto T, Kadoya C, Domino EF. Electrophysiologic effects of propofol sedation. Anesth Analg 1994;79:1151-8.
10. Arden JR, Holley FO, Stanski DR. Increased sensitivity to etomidate in the elderly: initial distribution versus altered brain response. Anesthesiology 1986; 65:19-27.
11. Homer TD, Stanski DR. The effect of increasing age on thiopental disposition and anesthetic requirement. Anesthesiology 1985;62:714-24.
12. Bührer M, Maitre PO, Hung O, Stanski DR. Electroencephalographic effects of benzodiazepines: choosing an electroencephalographic parameter to measure the effect of midazolam on the central nervous system. Clin Pharmacol Ther 1990;48:544-54.
13. Smith NT, Westover CJJ, Quinn ML, Benthuysen JL, Dec-Silver H, Sanford TJJ. An electroencephalographic comparison of alfentanil with other narcotics and with thiopental. J Clin Monit 1985;1:236-44.
14. Sigl JC, Chamoun NG. An introduction to bispectral analysis for the electroencephalogram. J Clin Monit 1994;10:392-404.
15. Dumermuth G, Huber PJ, Kleiner B, Gasser T. Analysis of the interrelations between frequency bands of the EEG by means of the bispectrum. A preliminary study. Electroencephalogr Clin Neurophysiol 1971;31:137-48.
16. Barnett TP, Johnson LC, Naitoh P, Hicks N, Nute C. Bispectrum analysis of electroencephalogram signals during waking and sleeping. Science 1971;172:401-2.
17. Kearse LA Jr, Manberg P, Chamoun N, deBros F, Zaslavsky A. Bispectral analysis of the electroencephalogram correlates with patient movement to skin incision during propofol/nitrous oxide anesthesia. Anesthesiology 1994;81:1365-70.
18. Leslie K, Sessler DI, Schroeder M, Walters K. Propofol blood concentration and the bispectral index predict suppression of learning during propofol/epidural anesthesia in volunteers. Anesth Analg 1995;81:1269-74.
19. Dyck JB, Varvel J, Hung O, Shafer SL. The pharmacodynamics of propofol vs age [abstract]. Can J Anaesth 1991;38:A106.
20. Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age: a simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987;240:159-66.
21. Lemmens HJM, Dyck JB, Shafer SL, Stanski DR. Pharmacokinetic-pharmacodynamic modeling in drug development: application to the investigational opioid trefentanil. Clin Pharmacol Ther 1994;56:261-71.
22. Fiset P. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam. Clin Pharmacol Ther 1995;58:567-82.
23. Schnider TW, Minto CF, Stanski DR. The effect compartment concept in pharmacodynamic modelling. Anaesth Pharmacol Rev 1994;2:204-13.
24. Schwilden H, Stoeckel H, Schüttler J. Closed-loop feedback control of Propofol anaesthesia by quantitative EEG analysis in humans. Br J Anaesth 1989;62: 290-6.
25. Lemmens HJM, Bovill JG, Hennis PJ, Gladines MPRR, Burm AGL. Alcohol consumption alters the pharmacodynamics of alfentanil. Anesthesiology 1989;71:669-74.
26. Ausems ME, Hug CC Jr, Stanski DR, Burm AGL. Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery. Anesthesiology 1986;65:362-73.
27. Billard V, Shafer SL. Does the EEG measure therapeutic opioid drug effect? In: Schwilden H, Stoeckel H, editors. Control and automation in anaesthesia. Berlin: Springer, 1995:79-95.
28. Veselis RA, Reinsel RA, Marino P, Wronski M. EEG power spectrum changes during propofol sedation [abstract]. Anesthesiology 1991;75:A181.
29. Schüttler J, Schwilden H, Stoeckel H. Pharmacokinetic-dynamic modeling of diprivan [abstract]. Anesthesiology 1986;65:A549.
30. Vuyk J, Engbers FHM, Lemmens HJM, Burm AG, Vletter AA, Gladines MP, et al. Pharmacodynamics of propofol in female patients. Anesthesiology 1992; 77:3-9.
31. Shafer A, Doze VA, Shafer SL, White PF. Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology 1988; 69:348-56.
32. Breimer LTM, Hennis PJ, Burm AGL, Danhof M, Bovill JG. Quantification of the EEG effect of midazolam by aperiodic analysis in volunteers: pharmacokinetic/pharmacodynamic modelling. Clin Pharmacokinet 1990;18:245-53.
33. Breimer LTM, Burm AGL, Danhof M, Hennis PJ, Vlertter AA, de Voogt JW, et al. Pharmacokinetic-pharmacodynamic modelling of the interaction between flumazenil and midazolam in volunteers by aperiodic EEG analysis. Clin Pharmacokinet 1991;20: 497-508.
34. Schnider TW, Minto CF, Fiset P, Gregg KM, Shafer SL. Semilinear canonical correlation applied to the measurement of the electroencephalographic effects of midazolam and flumazenil reversal. Anesthesiology 1996;84:510-9.
35. Leslie K, Sessler DI, Smith WD. Prediction of movement during propofol/nitrous oxide anesthesia: performance of concentration, electroencephalographic, pupillary, and hemodynamic indicators. Anesthesiology 1996;84:52-63.
36. Vernon J, Lang E, Sebel P. Prediction of movement using bispectral electroencephalographic analysis during propofol/alfentanil or isoflurane/alfentanil anesthesia. Anesth Analg 1995;80:780-5.
37. Liu J, Singh H, White PF. Electroencephalogram bispectral analysis predicts the depth of midazolam-induced sedation. Anesthesiology 1996;84:64-9.